Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk
American Journal of Epidemiology · 03.06.2026 · 195 (6) · 1572-1584
DOI: 10.1093/aje/kwag055 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Epidemiology, online erschienen am 10.03.2026. Verfasst von Ting Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States. Hauptthemen laut MEDLINE: ABO Blood-Group System, Carcinoma, Pancreatic Ductal, Lewis Blood Group Antigens, Pancreatic Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the US Army Medical Research Acquisition Activity through the Peer Review Cancer Research Program Discovery Award, HHS, NIH HHS.
Abstract (Originalsprache)
The ABO locus is associated with pancreatic ductal adenocarcinoma (PDAC). Potential metabolic mechanisms underlying these associations have not been investigated. We examined associations between genotype-derived ABO blood group (rs505922 and rs8176746) and 1478 prediagnostic serum metabolites in 4042 participants from 8 nested case–control studies within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study using linear regression and fixed-effect meta-analysis. We then examined associations between the identified ABO-associated metabolites and PDAC in 2 nested case–control studies (493 cases, 640 controls) using logistic regression and evaluated metabolite mediation of the ABO-PDAC association. Non-O and A (vs O) blood groups were associated with 13 and 20 metabolites, respectively, at false discovery rate <0.20, with 9 in common. The ABO-associated metabolites, sphingosine (non-O: β = 0.15), aspartate (A: β = –0.11), and aspartylphenylalanine (A: β = –0.16) were positively, and fibrinopeptide B (1-13) (non-O: β = 0.13; A: β = 0.21) was inversely associated with PDAC (OR = 0.96-1.07 per SD change log10-metabolite, P <.05) after adjustment for blood group. Non-O (OR = 1.50 [95% CI, 1.16-1.94]) and A (OR = 1.46 [95% CI, 1.10-1.92]) (vs O) blood groups were associated with PDAC, however none of the ABO associated metabolites significantly mediated the association between ABO blood group and PDAC. Our results suggest the ABO-associated metabolites are independent risk factors for PDAC. Trial registration: NCT00342992 and NCT00339495.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
- Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, United States.
- Cancer Control and Population Sciences Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
ORCID-Profile: Ting Zhang, Steven C Moore, Erikka Loftfield, Kai Yu, Rachael Z Stolzenberg-Solomon
Förderung
- the US Army Medical Research Acquisition Activity through the Peer Review Cancer Research Program Discovery Award
- HHS
- NIH HHS
- US National Cancer Institute
- the Intramural Research Program of the Division of Cancer Epidemiology and Genetics
- Department of Health and Human Services
- National Institutes of Health
Zitieren
APA
Zhang, T., Moore, S. C., Fu, S., Albanes, D., Liao, L. M., Loftfield, E., Playdon, M. C., Weinstein, S. J., Yu, K., & Stolzenberg-Solomon, R. Z. (2026). Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. American Journal of Epidemiology, 195(6), 1572-1584. https://doi.org/10.1093/aje/kwag055
Vancouver
Zhang T, Moore SC, Fu S, Albanes D, Liao LM, Loftfield E, et al. Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. American Journal of Epidemiology. 2026;195(6):1572-1584. doi:10.1093/aje/kwag055
BibTeX
@article{Zhang2026,
author = {Zhang, Ting and Moore, Steven C and Fu, Sheng and Albanes, Demetrius and Liao, Linda M and Loftfield, Erikka and Playdon, Mary C and Weinstein, Stephanie J and Yu, Kai and Stolzenberg-Solomon, Rachael Z},
title = {Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk},
journal = {American Journal of Epidemiology},
year = {2026},
volume = {195},
number = {6},
pages = {1572--1584},
doi = {10.1093/aje/kwag055}
}
EUVIMED